Display options
Share it on

Iran Red Crescent Med J. 2012 Nov;14(11):722-6. doi: 10.5812/ircmj.3611. Epub 2012 Nov 15.

Expression of Testis Specific Genes TSGA10, TEX101 and ODF3 in Breast Cancer.

Iranian Red Crescent medical journal

Mehdi Dianatpour, Parvin Mehdipour, Karim Nayernia, Maryam-Beigom Mobasheri, Soudeh Ghafouri-Fard, Shahram Savad, Mohammad Hossein Modarressi

Affiliations

  1. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.

PMID: 23396665 PMCID: PMC3560543 DOI: 10.5812/ircmj.3611

Abstract

BACKGROUND: Breast cancer is the most common malignancy in women around the world so finding new biomarkers for early detection and also study on molecular aspects of breast cancer is valuable. Cancer testis genes are a group of genes expressed solely in testis and in a range of human malignancies.

OBJECTIVES: In this study we determined the expression of cancer testis genes Tsga10, TEX101 and ODF3 in patients with breast cancer.

MATERIALS AND METHODS: Fifty patients with breast cancer were enrolled in this study. Breast cancer cell lines MCF-7 and MDA-MB-231 were also used to determine the expression of testis cancer genes. For both patients and cell lines, cancer testis genes of TSGA10, TEX101 and ODF3 were determined by RT-PCR. The presence of auto antibody against these genes in patients' serums was carried on by ELISA method.

RESULTS: Seventy percent of patients showed TSGA10 expression but none of them showed expression of TEX101 and ODF3. Fourteen percent of patients were positive for anti TSGA10 but all patients were negative for anti TEX101 and anti ODF3. Both of breast cancer cell lines exhibited very strong expression of TSGA10.

CONCLUSIONS: Because of the important roles of Tsga10 in cell proliferation, we concluded that this gene may have a role in proliferation and survival of breast cancer cells and could be used for diagnosis and immunotherapy of breast cancer.

Keywords: Breast Cancer; Gene; ODF3; TEX101; TSGA10; Testis

References

  1. Nat Rev Cancer. 2005 Aug;5(8):615-25 - PubMed
  2. Ann Oncol. 2011 Jan;22(1):98-103 - PubMed
  3. CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 - PubMed
  4. Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3362-4 - PubMed
  5. Eur J Cancer. 2012 Jan;48(1):12-23 - PubMed
  6. Cancer Immunol Immunother. 2011 Jul;60(7):999-1007 - PubMed
  7. Br J Dermatol. 2010 Apr;162(4):772-9 - PubMed
  8. J Exp Clin Cancer Res. 2011 Jan 06;30:2 - PubMed
  9. Nucleic Acids Res. 2009 Jan;37(Database issue):D816-9 - PubMed
  10. Gene. 2001 Jan 10;262(1-2):249-55 - PubMed
  11. Microsc Res Tech. 1992 Jan 1;20(1):3-33 - PubMed
  12. Cancer Immun. 2004 Jan 23;4:1 - PubMed
  13. Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20422-7 - PubMed
  14. Arch Med Res. 2010 Apr;41(3):195-200 - PubMed
  15. Arch Iran Med. 2009 Jul;12(4):395-404 - PubMed
  16. Cancer Res. 2010 Jun 1;70(11):4569-79 - PubMed
  17. Cancer Detect Prev. 2007;31(4):296-302 - PubMed
  18. PLoS One. 2011 Mar 18;6(3):e17876 - PubMed

Publication Types